Respiratory Medicine
Volume 103, Issue 9 , Pages 1366-1375, September 2009

Asthma patients' self-reported behaviours toward inhaled corticosteroids

  • Laurent Laforest

      Affiliations

    • CHU Lyon, Unité de Pharmacoépidémiologie, Service de Neurologie, Hôpital Pierre Wertheimer, 59 Boulevard Pinel, 69677 Bron, France
  • ,
  • Abdelkader El Hasnaoui

      Affiliations

    • Epidemiology Department, GSK Laboratory, 100 Route de Versailles, 78163 Marly-le-Roi, France
  • ,
  • Céline Pribil

      Affiliations

    • Epidemiology Department, GSK Laboratory, 100 Route de Versailles, 78163 Marly-le-Roi, France
  • ,
  • Cécile Ritleng

      Affiliations

    • CHU Lyon, Unité de Pharmacoépidémiologie, Service de Neurologie, Hôpital Pierre Wertheimer, 59 Boulevard Pinel, 69677 Bron, France
  • ,
  • Liesl M. Osman

      Affiliations

    • University of Oxford, NDM Strategic, Nuffield Department of Medicine, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, UK
  • ,
  • Marie-Sophie Schwalm

      Affiliations

    • Cegedim, 90–92 Route de la Reine, 92100 Boulogne-Billancourt, France
  • ,
  • Philippe Le Jeunne

      Affiliations

    • Cegedim, 90–92 Route de la Reine, 92100 Boulogne-Billancourt, France
  • ,
  • Eric Van Ganse

      Affiliations

    • CHU Lyon, Unité de Pharmacoépidémiologie, Service de Neurologie, Hôpital Pierre Wertheimer, 59 Boulevard Pinel, 69677 Bron, France
    • Corresponding Author InformationCorresponding author. Unité de Neuro-épidémiologie et de Pharmaco-épidémiologie, Hôpital Neurologique Pierre Wertheimer, 59 Boulevard Pinel, 69677 BRON Cedex, France. Tel.: +33 (0) 472 129 709; fax: +33 (0) 472 129 714.

Received 27 October 2008; accepted 12 March 2009. published online 27 April 2009.

Summary 

Background

Patient adherence to recommended use of ICS is questionable in asthma, with irregular use or interruptions occurring frequently. Factors explaining discontinuation of controller therapy could orientate interventions. The characteristics of patients with interruptions of inhaled corticosteroids (ICSs), intentional or accidental, were investigated.

Methods

Asthma patients regularly prescribed ICS by GPs (Cegedim network) were included. Patients' characteristics and behaviours toward ICS (accidental/intentional interruptions, less frequent use of ICS and change in dosing) were identified from self-report questionnaires, and linked to data prescription database. Interrelations between declared behaviours toward ICS were studied with a Multiple Component Analysis (MCA) and the correlates of ICS interruptions were identified.

Results

During the past 3 months, 31.6% of 204 patients (mean age: 53.8 years, females: 59.3%) intentionally interrupted ICS when feeling better, 25.4% forgot ICS and 18.3% deliberately changed the doses. A quarter of patients considered constant use of respiratory medicines as unhealthy. MCA revealed that intentional, accidental interruptions and less frequent use of ICS were closely correlated. Risk of intentional interruption was increased when patients considered constant use of respiratory therapy to be unhealthy (OR=3.36, 95%CI=[1.47–7.66]). Conversely, risk was significantly lower when ICS was associated or combined with another controller (OR=0.24, 95%CI=[0.08–0.73]), compared to ICS in monotherapy. Less frequent interruptions were observed in patients older than 65 (OR=0.35, 95%CI=[0.13–0.89]).

Conclusions

Our study suggests that discontinuation of use of controllers is associated with other inadequate behaviours or beliefs about inhaled controllers. Efforts should be targeted at patients' perceptions and behaviours toward controller therapy.

Keywords: Adherence, Asthma, Inhaled corticosteroids, Survey

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(09)00090-0

doi:10.1016/j.rmed.2009.03.010

Respiratory Medicine
Volume 103, Issue 9 , Pages 1366-1375, September 2009